Exp Mol Med.  2016 Feb;48(2):e212. 10.1038/emm.2016.1.

STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance

Affiliations
  • 1Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. kskim@kribb.re.kr
  • 2Biomedical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
  • 3University of Science and Technology, Daejeon, Republic of Korea. chungbh@kribb.re.kr
  • 4Aging Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
  • 5Mutagenesis and Genomics Team, RIKEN BioResource Center, Tsukuba, Ibaraki, Japan.
  • 6College of Biosciences and Biotechnology, Chung-Nam National University, Daejeon, Republic of Korea.
  • 7Department of Brain and Cognitive Sciences, Ewha Womans University, Seoul, Republic of Korea.
  • 8Department of Chemistry and Nano Science, Ewha Womans University, Seoul, Republic of Korea.
  • 9BioNanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
  • 10Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. hjlee7@kribb.re.kr

Abstract

Striatal-enriched protein tyrosine phosphatase (STEP) is abundantly expressed in the striatum, which strongly expresses dopamine and opioid receptors and mediates the effects of many drugs of abuse. However, little is known about the role of STEP in opioid receptor function. In the present study, we generated STEP-targeted mice carrying a nonsense mutation (C230X) in the kinase interaction domain of STEP by screening the N-ethyl-N-nitrosourea (ENU)-driven mutant mouse genomic DNA library and subsequent in vitro fertilization. It was confirmed that the C230X nonsense mutation completely abolished functional STEP protein expression in the brain. STEP(C230X−/−) mice showed attenuated acute morphine-induced psychomotor activity and withdrawal symptoms, whereas morphine-induced analgesia, tolerance and reward behaviors were unaffected. STEP(C230X−/−) mice displayed reduced hyperlocomotion in response to intrastriatal injection of the μ-opioid receptor agonist DAMGO, but the behavioral responses to δ- and κ-opioid receptor agonists remained intact. These results suggest that STEP has a key role in the regulation of psychomotor action and physical dependency to morphine. These data suggest that STEP inhibition may be a critical target for the treatment of withdrawal symptoms associated with morphine.


MeSH Terms

Analgesia*
Animals
Brain
Codon, Nonsense
Dopamine
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
Ethylnitrosourea
Fertilization in Vitro
Gene Library
Mass Screening
Mice
Morphine*
Phosphotransferases
Protein Tyrosine Phosphatases
Receptors, Opioid
Reward*
Street Drugs
Substance Withdrawal Syndrome*
Codon, Nonsense
Dopamine
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
Ethylnitrosourea
Morphine
Phosphotransferases
Protein Tyrosine Phosphatases
Receptors, Opioid
Street Drugs
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr